Brandes Investment Partners LP Increases Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Brandes Investment Partners LP lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 102.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,638 shares of the medical instruments supplier's stock after purchasing an additional 23,626 shares during the quarter. Brandes Investment Partners LP's holdings in DENTSPLY SIRONA were worth $1,166,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the stock. LRI Investments LLC increased its position in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after acquiring an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $32,000. Central Pacific Bank Trust Division purchased a new position in shares of DENTSPLY SIRONA in the first quarter worth approximately $64,000. Mather Group LLC. bought a new stake in DENTSPLY SIRONA during the first quarter valued at approximately $72,000. Finally, AM Squared Ltd purchased a new stake in DENTSPLY SIRONA during the second quarter valued at approximately $90,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.94 on Tuesday, reaching $26.12. The company had a trading volume of 1,949,389 shares, compared to its average volume of 3,044,355. The stock has a market capitalization of $5.42 billion, a PE ratio of -59.14, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 12 month low of $23.58 and a 12 month high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The firm's 50 day moving average price is $25.55 and its 200 day moving average price is $27.52.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the firm posted $0.51 earnings per share. As a group, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -145.45%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on XRAY. Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research note on Thursday, July 18th. Evercore ISI reduced their price target on DENTSPLY SIRONA from $28.00 to $27.00 and set an "outperform" rating for the company in a research report on Tuesday, July 9th. Needham & Company LLC reaffirmed a "buy" rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research note on Monday, July 22nd. Finally, Barrington Research restated an "outperform" rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of "Moderate Buy" and an average target price of $33.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.